Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

Medicaid expansion under the ACA improved long-term survival for younger adults with operable lung cancer, despite no earlier ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

With most lung cancers in India diagnosed at advanced stages, experts say low-dose CT screening for high-risk groups like ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Trump wants to own Venezuela’s oil, but its largest oil customer is speeding toward clean energy New search for missing ...

The Lung Cancer Research Foundation® (LCRF) recently awarded five new research grants in the following areas: three LCRF ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

The National Football League Alumni Association (NFL Alumni) and the Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control have expanded the "GEAR UP Against ...